PROCEPT BioRobotics Corporation (PRCT)
| Market Cap | 1.07B -43.5% |
| Revenue (ttm) | 337.34M +22.7% |
| Net Income | -109.76M |
| EPS | -1.95 |
| Shares Out | 57.27M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 109,544 |
| Open | 18.35 |
| Previous Close | 18.15 |
| Day's Range | 18.34 - 18.67 |
| 52-Week Range | 16.67 - 38.11 |
| Beta | 0.92 |
| Analysts | Hold |
| Price Target | 22.25 (+19.43%) |
| Earnings Date | Nov 4, 2026 |
About PRCT
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology in the United States and internationally. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia. The company also provides HYDROS Robotic System, which provides Aquablation therapy image-guided robotic therapy to treat males suffering from lower urinary tract symptoms due to benign prostatic hype... [Read more]
Financial Performance
In 2025, PROCEPT BioRobotics's revenue was $308.05 million, an increase of 37.22% compared to the previous year's $224.50 million. Losses were -$95.57 million, 4.55% more than in 2024.
Financial StatementsAnalyst Summary
According to 15 analysts, the average rating for PRCT stock is "Hold." The 12-month stock price target is $22.25, which is an increase of 19.43% from the latest price.
News
PROCEPT BioRobotics® to Report Third Quarter 2026 Financial Results on November 4th, 2026
SAN JOSE, Calif., Oct. 12, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (the “Company”) (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transfor...
Procept BioRobotics initiated with an Overweight at Barclays
Barclays analyst Christopher Pasquale initiated coverage of Procept BioRobotics (PRCT) with an Overweight rating and $30 price target The firm rolled out coverage of the medical suppliers and devices ...
Kaplan Fox Encourages PROCEPT BioRobotics Corporation (NASDAQ: PRCT) Investors Seeking Recovery to Contact the Firm Before September 22, 2026
NEW YORK, Sept. 21, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against PROCEPT BioRobotics Corporation (“PROCEPT” or the “Company”) (NASD...
Long-Term Shareholders of PROCEPT BioRobotics Corporation (PRCT) Are Encouraged to Contact Johnson Fistel Regarding Potential Claims
SAN DIEGO, Sept. 21, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential claims on behalf of current, long-term shareholders of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) agai...
Kaplan Fox Reminds PROCEPT BioRobotics Corporation (PRCT) Investors That They Have Until September 22, 2026 to Move for Lead Plaintiff
New York, New York--(Newsfile Corp. - September 16, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against PROCEPT BioRobotics Corporation ("PROCEPT" or the "...
PROCEPT BioRobotics Transcript: 2026 Global Healthcare Conference
Significant BPH market opportunity remains, with Aquablation offering clinical advantages and driving revenue growth. Operational improvements, higher ASPs, and new marketing initiatives support long-term growth targets, while the upcoming WATER IV trial could expand into prostate cancer treatment.
LAWSUIT NOTICE: NASDAQ: PRCT Investors who lost money with PROCEPT BioRobotics Corporation shares should contact the Shareholders Foundation
SAN DIEGO, Sept. 15, 2026 /PRNewswire/ -- The Shareholders Foundation, Inc. announced that a lawsuit was filed for certain investors in shares of PROCEPT BioRobotics Corporation (NASDAQ: PRCT).
Kaplan Fox & Kilsheimer LLP Alerts PROCEPT BioRobotics Corporation (PRCT) Investors to Their Right to Seek Lead Plaintiff Status Before September 22, 2026
New York, New York--(Newsfile Corp. - September 14, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against PROCEPT BioRobotics Corporation ("PROCEPT" or the "...
Kaplan Fox & Kilsheimer LLP Encourages Investors of PROCEPT BioRobotics Corporation (PRCT) to Contact the Firm Ahead of the Lead Plaintiff Deadline on September 22, 2026
New York, New York--(Newsfile Corp. - September 10, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against PROCEPT BioRobotics Corporation ("PROCEPT" or the "...
Kaplan Fox Alerts PROCEPT BioRobotics Corporation (NASDAQ: PRCT) Investors to an Approaching Lead Plaintiff Deadline on September 22, 2026
NEW YORK, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against PROCEPT BioRobotics Corporation (“PROCEPT” or the “Company”) (NASD...
Kaplan Fox Reminds PROCEPT BioRobotics Corporation (NASDAQ: PRCT) Investors to Seek a Leadership Role Before Deadline on September 22, 2026
NEW YORK, Sept. 04, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against PROCEPT BioRobotics Corporation (“PROCEPT” or the “Company”) (NASD...
Kaplan Fox Notifies Investors of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) of the Lead Plaintiff Deadline on September 22, 2026
NEW YORK, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against PROCEPT BioRobotics Corporation (“PROCEPT” or the “Company”) (NASD...
Kaplan Fox Advises Investors of PROCEPT BioRobotics Corporation (PRCT) to Contact the Firm Before the Deadline on September 22, 2026
New York, New York--(Newsfile Corp. - September 1, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against PROCEPT BioRobotics Corporation ("PROCEPT" or the "C...
Kaplan Fox Encourages PROCEPT BioRobotics Corporation (PRCT) Investors Who Suffered Losses to Seek a Leadership Role Before September 22, 2026
New York, New York--(Newsfile Corp. - August 31, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against PROCEPT BioRobotics Corporation ("PROCEPT" or the "Com...
Kaplan Fox Advises PROCEPT BioRobotics Corporation (NASDAQ: PRCT) Investors to Act Before the Lead Plaintiff Deadline on September 22, 2026
NEW YORK, Aug. 26, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against PROCEPT BioRobotics Corporation (“PROCEPT” or the “Company”) (NASDA...
Notice to Long-Term Shareholders of PROCEPT BioRobotics Corporation (PRCT): Grabar Law Office Investigates Claims on Your Behalf
Philadelphia, Pennsylvania--(Newsfile Corp. - August 26, 2026) - Grabar Law Office is investigating claims on behalf of shareholders of PROCEPT BioRobotics Corporation (NASDAQ: PRCT). What is This Inv...
PROCEPT BioRobotics® to Attend the Baird 2026 Global Healthcare Conference on September 15, 2026
SAN JOSE, Calif., Aug. 17, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (the “Company”) (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transfor...
PRCT Shareholders Have Rights - If You Lost Money Investing in PROCEPT BioRobotics Corporation Contact Robbins LLP for Information About Recovering Your Losses
SAN DIEGO, Aug. 11, 2026 /PRNewswire/ -- Robbins LLP reminds investors that a securities class action has been filed on behalf of all purchasers of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) commo...
PRCT Investor Announcement: PROCEPT BioRobotics Sued on behalf of Investors to Recover Losses after Artificially Inflated Revenue Leads to 18% Stock Drop
A securities fraud class action lawsuit has been filed on behalf of Procept investors after its stock plummeted 18% because Procept allegedly artificially inflated its financial performance via an ext...
Kaplan Fox Notifies PROCEPT BioRobotics Corporation (PRCT) Investors of an Upcoming Lead Plaintiff Deadline on September 22, 2026
New York, New York--(Newsfile Corp. - August 10, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against PROCEPT BioRobotics Corporation (NASDAQ: PRCT) ("PROCE...
Procept BioRobotics management to meet with Piper Sandler
Meeting to be held on August 10-13 hosted by Piper Sandler.
Kaplan Fox Urges PROCEPT BioRobotics Corporation (PRCT) Investors Seeking Recovery to Contact the Firm Before September 28, 2026
New York, New York--(Newsfile Corp. - August 5, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against PROCEPT BioRobotics Corporation ("PROCEPT" or the "Comp...
Procept BioRobotics price target lowered to $23 from $30 at Evercore ISI
Evercore ISI lowered the firm’s price target on Procept BioRobotics (PRCT) to $23 from $30 and keeps an Outperform rating on the shares.
Procept BioRobotics price target lowered to $21 from $25 at Truist
Truist lowered the firm’s price target on Procept BioRobotics (PRCT) to $21 from $25 and keeps a Hold rating on the shares.
Procept BioRobotics price target lowered to $28 from $34 at TD Cowen
TD Cowen analyst Joshua Jennings lowered the firm’s price target on Procept BioRobotics (PRCT) to $28 from $34 and keeps a Buy rating on the shares. The firm said they…